Spyre Therapeutics, Inc. SYRE
Set alert
96.56 USD -2.40 -2.43%
At close · Oct 30
96.45 -0.11 -0.11%
After hours · Oct 30, 4:00 PM ET
94.68 Day range 98.96
22.18 52-week range 108.92
- YTD
- +194.75%
- 1 year
- +298.02%
- Open
- 96.78
- Prev close
- 98.96
- Mkt cap
- 9.02B
- Vol
- 661.13K
- Avg vol
- 1.21M
- EPS
- -1.92
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 94.68
- High
- 98.96
- Forward P/E
- -27.55
- Beta
- 3.11
- Short ratio
- 7.98
- Inst. own
- 108.53%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 90.28
- 200-d avg
- 72.91
- 1y target
- 122.33
1Y chart
Events in this range
- Nov 4, 2025Earnings: -0.15; estimate -0.76076; surprise 80.28%
- Feb 19, 2026Earnings: -0.7; estimate -0.66; surprise -6.06%
- May 5, 2026Earnings: -0.74; estimate -0.66; surprise -12.12%
- Aug 4, 2026Earnings: -0.36; estimate -0.75885; surprise 52.56%
- Sep 8, 2026Rating: BTIG · Buy → Buy
- Sep 9, 2026Rating: Wedbush · Outperform → Outperform
- Oct 1, 2026Rating: BTIG · Buy → Buy
- Oct 1, 2026Rating: JP Morgan · — → Overweight
- Oct 12, 2026Rating: UBS · — → Buy
- Oct 19, 2026Rating: BTIG · Buy → Buy
Signals (35)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 5 days ago |
| SMA: Bearish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 19, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 21, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| RSI: Overbought | Apr 30, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| RSI: Overbought | Mar 31, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 26, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 5, 2026 | 8 months ago |
| RSI: Overbought | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Feb 4, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 20, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 16, 2025 | 10 months ago |
| RSI: Overbought | Dec 3, 2025 | 11 months ago |
| RSI: Overbought | Nov 25, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 24, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 4, 2025 | 12 months ago |
Compare SYRE
Chart and line up SYRE against other symbols or a saved comparison set.
- SYRE Spyre Therapeutics, Inc.
96.56
-2.40 -2.43%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | SYRE | SPY | QQQ |
|---|---|---|---|
| Last price | 96.56 | 755.72 | 690.49 |
| Change | -2.40 | -13.64 | -24.85 |
| Change % | -2.43% | -1.77% | -3.47% |
| Open | 96.78 | 761.38 | 697.13 |
| Day high | 98.96 | 761.46 | 698.63 |
| Day low | 94.68 | 750.36 | 683.45 |
| Previous close | 98.96 | 769.36 | 715.34 |
| Volume | 661.13K | 77.70M | 85.24M |
| Average volume | 1.21M | 41.22M | 34.57M |
| Market cap | 9.02B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -1.92 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 108.92 | 779.09 | 759.66 |
| 52-week low | 22.18 | 631.97 | 558.28 |
| 1-week return | +6.90% | -0.559233% | -1.97% |
| 1-month return | +8.46% | -0.906075% | -6.66% |
| 3-month return | -4.87% | +1.89% | +1.02% |
| 6-month return | +29.70% | +5.16% | +3.41% |
| Year-to-date return | +194.75% | +10.82% | +12.40% |
| 1-year return | +298.02% | +11.16% | +10.29% |
| 2-year return | +196.83% | +32.90% | +42.71% |
| 50-day moving average | 90.28 | 767.63 | 725.41 |
| 200-day moving average | 72.91 | 728.53 | 679.17 |
| Target price | 122.33 | — | — |
| Beta | 3.11 | 0.00 | 0.00 |
| Short ratio | 7.98 | — | — |
| Institutional ownership | 108.53% | — | — |